Navigation Links
Cannabis can Help to Treat Allergies, Autoimmune Disorders

Latest research suggests that cannabis, also known as marijuana or ganja, can help in the treatment of allergies and autoimmune disorders that occur when body tissues are attacked by its own immune system.

Researchers led by Andreas Zimmer, at the University of Bonn, used tetrahydrocannabinol (THC), the active ingredient in the cannabis plant to treat mice and found that it reduced skin allergies.

However, the researchers warned that people who currently suffer from autoimmune diseases should not try to self-medicate marijuana because of its side effects, reported the online edition of the New Scientist.

The human body contains endocannabinoids, which are marijuana like substances. They are produced in the body naturally.

The researchers created a group of mice that lack the receptor for endocannabinoids and noticed that the mice soon developed a severe skin allergy to the nickel in the metal tags the researchers had fastened to their ears.

Zimmer set up a series of experiments to test the anti-allergy effect of natural and synthetic THC compounds and found that they reduced skin irritation by half.

The researches also said they found that mouse skin cells exposed to synthetic THC release fewer cytokines, chemicals that attract immune cells to the site of infection or irritation.


'"/>




Page: 1

Related medicine news :

1. Cannabis for pain
2. Cannabis to be tested to help patients with respiratory diseases
3. Cannabis exerts protective effect against cancer
4. Relief For British MS Patients: Cannabis-Based Oral Spray
5. Alcohol And Drug Abuse (Cannabis) Leading Causes For Road Traffic Accidents
6. Government May Downgrade Cannabis
7. Can Cannabis Cause Madness?
8. Campaigners Say No To Cannabis Reclassification
9. No Increased Schizophrenia Risk With Use Of Cannabis
10. Tackling of Cannabis Addiction
11. Australia Set To Implement A national Strategy Tackle Cannabis Abuse
Post Your Comments:
(Date:7/25/2008)...s second quarter financial results -, LAVAL, QC, ...SX: DDS;,NASDAQ: DDSS) today announced that it wil...30 a.m. (ET) to discuss its second quarter 2008,fi...quarter 2008 financial,results via news release at... the conference call by telephone, dial 416-646-30...
(Date:7/25/2008)...oducts reduces lung function, increases asthma ris...(HealthDay News) -- A clean, fresh-smelling home m...hat type of cleaning and air freshening products y...e to cleaning products or air fresheners that cont...ed 1,4 dicholorobenzene (1,4 DCB), can reduce lung...
(Date:7/25/2008)...swire/ -- BeaconEquity.com announces the,availabil... Investors can view all of the daily trading notes..., Today,s Trade Alerts include: DUSA Pharmaceutic...cals Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,...nc. (Nasdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABA...
(Date:7/25/2008)... of Marketing Exclusivity Begins -, CORONA, Calif...ceuticals, Inc. (NYSE: WPI ), a leading specialty...subsidiary has commenced commercial,shipment of it...in the 40mg,strength from its Davie, Florida manuf... Watson has 180 days of marketing exclusivity for ...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
...1,000 pounds a measure. Available at the main bar...ie Walker 1805 has just gone on sale. It is claime...ave been made to celebrate the birthday of the lab...arcity value has been enhanced, the makers claim, ...
...kness (AMS), which affects about half of those asc...hreatening complications such as pulmonary or cere...AMS is thought to have increased over the past 25 ...media exposure, trekking guidebooks and the wide a...
...tish Youngman willingly came forward to donate mor...ansplant has been successful. David and Stephen ...r The 20-year-old David Lomas from Cumbria said he...y when his father Stephen, 51, asked for it. <...
... 2003 have not absorbed dangerous levels of deplet...t in Occupational and Environmental Medicine. De...e armoured vehicles, and spontaneously combusts on... These can either be breathed in or eaten/drunk in...
Other Medicine News:Health News:Scot's National Drink, Now Available at 1,000 Pounds a Nip 2Health News:Acute Mountain Sickness may Lead to Pulmonary or Cerebral Edema 2Health News:Son Donates Part of Liver to Ailing Father, Transplant Successful 2
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Medic...g solutions for more than 20 years, has entered,th...hnology to measure,regional oxygen saturation. Tod...s the continuous monitoring of the regional blood ...arly testing data and outcomes from an ongoing cli...
(Date:7/22/2008)... Study Demonstrates Feasibility and Efficacy of Tr...ary Liver Cancer, SAN FRANCISCO, and YONGIN-SI, S... (San Francisco, CA and Ottawa, Ontario), and its ...today that novel findings from,a Phase I clinical ...monstrated that the product was well-tolerated and...
(Date:7/22/2008)... CEO Geoffrey Allan Will Stress the Importance to ...iologics Approval Pathway, RICHMOND, Va., July 22... INSM) a developer of follow-on biologics and biop...n, Ph.D., CEO of Insmed, will present at a,Congres...uss the,significant need for establishing an appro...
(Date:7/22/2008)...st Developed and Validated by Columbia University ..., Proprietary MicroRNA Technology, The Test Diff...ll Lung Cancer (NSCLC), Classifying Squamous-Cell...96 Percent and Specificity of 90 Percent,This is t...NAs, Sensitivity as Biomarkers for Accura...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 1David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 2David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 3David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 4Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 1Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 2Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 3PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 1PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 2PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 3PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 4PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 5PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 6PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 7PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 8PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 9Diabetes Linked to Blood Vessel Inflammation 7756 1Diabetes Linked to Blood Vessel Inflammation 7756 2
...lia--(BUSINESS WIRE)--Jul 5, 2007 - Australian,bio... the,completion of apricitabine,s controlled, doub...k segment of its Phase IIb trial.,Patients have no...ial (weeks 24 to 48) and will continue to receive ...ily treatment regime.,The Company expects to relea...
...xas--(BUSINESS WIRE)--Jul 5, 2007 - Repros,Therape... article,has been published in the July 1, 2007 is... a new approach to the treatment of,breast cancer ...rom,a study conducted in an accepted in vivo rat m...collaboration with scientists,from the University ...
Other Medicine Technology:Avexa's Apricitabine Clinical Trial Update 2Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 2Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 3Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 4
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: